0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

β-Blocker Use for Patients With or at Risk for Coronary Artery Disease—Reply

Sripal Bangalore, MD, MHA; P. Gabriel Steg, MD; Deepak L. Bhatt, MD, MPH
JAMA. 2013;309(5):438. doi:10.1001/jama.2012.128872.
Text Size: A A A
Published online

Extract

In Reply: Dr Shang contends that our results are mostly confirmation of a well-known fact that atenolol is ineffective and may not be generalized to other β-blockers such as carvedilol. This statement highlights the discordance between trials and practice and an optimism bias based on perceived benefit of a newer agent assessed by surrogate end points only.

The well-known fact that atenolol is ineffective has not translated into clinical practice—atenolol was the second top generic drug based on retail dollars in 2010.1 The data on β-blocker use in patients without heart failure are based on older agents and as a result, there is no guideline recommendation of a preferred β-blocker.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

February 6, 2013
Charles Shang, MD
JAMA. 2013;309(5):438. doi:10.1001/jama.2012.128869.
February 6, 2013
Frans H. Rutten, MD, PhD; Rolf H. H. Groenwold, MD, PhD
JAMA. 2013;309(5):438. doi:10.1001/jama.2012.128865.
February 6, 2013
Dominique Costagliola, PhD; Miguel A. Hernán, MD, PhD
JAMA. 2013;309(5):438. doi:10.1001/jama.2012.128862.
CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Jobs
brightcove.createExperiences();